Emc Capital Management Castle Biosciences Inc Transaction History

Emc Capital Management

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$33.17 - $46.98 $824,174 - $1.17 Million	-24,847 Closed	0 $0
Q3 2021 Nov 02, 2021	BUY	$60.13 - $77.6 $129,520 - $167,150	2,154 Added 9.49%	24,847 $1.55 Million
Q2 2021 Aug 09, 2021	SELL	$50.07 - $76.78 $188,713 - $289,383	-3,769 Reduced 14.24%	22,693 $1.66 Million
Q1 2021 May 05, 2021	SELL	$58.92 - $97.33 $97,335 - $160,789	-1,652 Reduced 5.88%	26,462 $1.81 Million
Q4 2020 Feb 24, 2021	BUY	$43.6 - $73.05 $1.23 Million - $2.05 Million	28,114 New	28,114 $1.89 Million

162

25.3M

82.2K

150K

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $559M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

Get notified when there are updates to the investment portfolio of Emc Capital Management, based on Form 13F filings with the SEC.

Stay updated on Emc Capital Management with notifications on news.